Show simple item record

dc.contributor.authorZhang, Chunhua
dc.contributor.authorJin, Ke
dc.contributor.authorXiao, Yanling
dc.contributor.authorCheng, Ying
dc.contributor.authorHuang, Zuhu
dc.contributor.authorWang, Shixia
dc.contributor.authorLu, Shan
dc.date2022-08-11T08:08:33.000
dc.date.accessioned2022-08-23T15:58:46Z
dc.date.available2022-08-23T15:58:46Z
dc.date.issued2013-10-01
dc.date.submitted2015-10-08
dc.identifier.citationHum Vaccin Immunother. 2013 Oct;9(10):2157-64. doi: 10.4161/hv.25656. Epub 2013 Jul 12. <a href="http://dx.doi.org/10.4161/hv.25656">Link to article on publisher's site</a>
dc.identifier.issn2164-5515 (Linking)
dc.identifier.doi10.4161/hv.25656
dc.identifier.pmid23851482
dc.identifier.urihttp://hdl.handle.net/20.500.14038/30511
dc.description.abstractRecent studies have demonstrated that DNA immunization is effective in eliciting antigen-specific antibody responses against a wide range of infectious disease targets. The polyclonal antibodies elicited by DNA vaccination exhibit high sensitivity to conformational epitopes and high avidity. However, there have been limited reports in literature on the production of monoclonal antibodies (mAb) by DNA immunization. Here, by using Clostridium difficile (C. diff) toxin A as a model antigen, we demonstrated that DNA immunization was effective in producing a panel of mAb that are protective against toxin A challenge and can also be used as sensitive reagents to detect toxin A from various testing samples. The immunoglobulin (Ig) gene usage for such mAb was also investigated. Further studies should be conducted to fully establish DNA immunization as a unique platform to produce mAb in various hosts.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=23851482&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906400/
dc.subjectAnimals
dc.subjectAntibodies, Bacterial
dc.subjectAntibodies, Monoclonal
dc.subjectBacterial Toxins
dc.subjectEnterotoxins
dc.subjectImmunization
dc.subjectMice, Inbred BALB C
dc.subjectVaccines, DNA
dc.subjectBiological Factors
dc.subjectGenetics and Genomics
dc.subjectImmunology and Infectious Disease
dc.subjectImmunology of Infectious Disease
dc.subjectImmunoprophylaxis and Therapy
dc.titlePotent monoclonal antibodies against Clostridium difficile toxin A elicited by DNA immunization
dc.typeJournal Article
dc.source.journaltitleHuman vaccines and immunotherapeutics
dc.source.volume9
dc.source.issue10
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/faculty_pubs/789
dc.identifier.contextkey7693440
html.description.abstract<p>Recent studies have demonstrated that DNA immunization is effective in eliciting antigen-specific antibody responses against a wide range of infectious disease targets. The polyclonal antibodies elicited by DNA vaccination exhibit high sensitivity to conformational epitopes and high avidity. However, there have been limited reports in literature on the production of monoclonal antibodies (mAb) by DNA immunization. Here, by using Clostridium difficile (C. diff) toxin A as a model antigen, we demonstrated that DNA immunization was effective in producing a panel of mAb that are protective against toxin A challenge and can also be used as sensitive reagents to detect toxin A from various testing samples. The immunoglobulin (Ig) gene usage for such mAb was also investigated. Further studies should be conducted to fully establish DNA immunization as a unique platform to produce mAb in various hosts.</p>
dc.identifier.submissionpathfaculty_pubs/789
dc.contributor.departmentDepartment of Medicine, Division of Infectious Diseases and Immunology
dc.source.pages2157-64


This item appears in the following Collection(s)

Show simple item record